Jyong Biotech MENS
NASDAQ MENS
$2.16 +0.04 (+1.89%)
At close: Sep 9, 2026 · 4:00 PM EDT

Jyong Biotech (MENS) Shares Outstanding (2024 - 2025)

Jyong Biotech (MENS) posted Shares Outstanding (Entity) of $76.0 million for Q4 2025, up 3.63% on a QoQ basis from $73.4 million in Q4 2024, and up 3.63% year-over-year from $73.4 million in Q4 2024.

Analysis

Jyong Biotech (MENS) Shares Outstanding (2024 - 2025) Analysis & Trends

Jyong Biotech has reported Shares Outstanding (Entity) for 2 years, with the latest figure at $76.0 million in Q4 2025.

  • On a quarterly basis, Shares Outstanding (Entity) rose 3.63% year-over-year to $76.0 million in Q4 2025; TTM through Dec 2025 was $76.0 million, a 3.63% increase from a year earlier, with the FY2025 full-year figure at $76.0 million, up 3.63% from the prior year.
  • Shares Outstanding (Entity) was $76.0 million for Q4 2025 at Jyong Biotech, up from $73.4 million in the prior quarter.
  • The five-year high for Shares Outstanding (Entity) was $76.0 million in Q4 2025, with the low at $73.4 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 2.41 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 1.77 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 1.94 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 5.70 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 1.22 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 210.89 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 200.38 Mn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 42.60 Mn
10 Jyong Biotech 159.89 Mn 159.89 Mn - 73.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 73.01 Mn
Jun 30, 2025 71.57 Mn
Dec 31, 2024 71.57 Mn